Clinical Trials Logo
  1. Home
  2. Panic Disorder
  3. NCT03360578
  4. Details
NCT03360578 Clinical Trial

Measuring Physiology to Determine if Pre-panic Attack Detection is Possible

Panic Disorder Clinical Trial

Official title:
Measuring Physiology in Individuals With Panic Disorder to Determine if Panic Attack Detection is Possible

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03360578
Other study ID # Pre-Panic Physiology
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 1, 2018
Est. completion date December 31, 2022

Study information
Verified date April 2022
Source Medical Psychology Center
Contact Jonathan Inz, PhD
Phone 978-921-4000
Email jinz@mpc.care
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Participants will be asked to wear a physiological monitoring device for 1 week and record when panic events occur. Once the device is returned, the data will be downloaded and analyzed.

Recruitment information / eligibility
Status Recruiting
Enrollment 46
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Panic disorder as described in the Diagnostic and Statistical Manual - 5 (DSM-5) Exclusion Criteria: - Pregnancy

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Garmin
A commercial grade health wearable

Locations
Country Name City State
United States Medical Psychology Center Beverly Massachusetts

Sponsors (1)
Lead Sponsor Collaborator
Medical Psychology Center

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Panic event A timestamp of when a panic attack occurred 1 year
Primary Heart Rate Beats per minute 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05868135 - Effects and Cost-effectiveness of e-Meistring - a Guided Internet-delivered Psychological Treatment
Active, not recruiting NCT05530642 - An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel N/A
Completed NCT02998502 - The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens N/A
Completed NCT01963806 - ACT-smart: Smartphone-supplemented iCBT for Social Phobia and/or Panic Disorder N/A
Completed NCT01955954 - Using the Canary Breathing System for Panic Disorder Patients N/A
Completed NCT01201967 - A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients Phase 4
Completed NCT00711737 - Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months N/A
Completed NCT00525226 - Evaluating the Effects of Stress in Pregnancy N/A
Completed NCT00605813 - Special Investigation Of Long Term Use Of Sertraline.
Completed NCT00353470 - Comparison of Psychotherapy Programs to Treat Panic Disorder Phase 3
Completed NCT00167479 - A Study of Risperidone Monotherapy in Bipolar Anxiety Phase 4
Completed NCT00540098 - Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder Phase 4
Completed NCT03233542 - The Association Between Physical Sensations and Thinking Styles N/A
Recruiting NCT05967468 - Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder N/A
Completed NCT02811458 - Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders N/A
Active, not recruiting NCT05124639 - Clinical Trial of a Group Self-management Support Program for Anxiety Disorders N/A
Completed NCT04592536 - A Trial of the Effect of CVL-865 on Panic Symptoms Induced by Carbon Dioxide Inhalation in Healthy Subjects Phase 1
Completed NCT00025974 - Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder N/A
Recruiting NCT02305537 - Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment N/A
Terminated NCT01680107 - D-cycloserine Augmented CBT for Panic Disorder Phase 3